| 08/06 | PTA-NEWS : Biofrontera AG: Biofrontera's license partner Louis Widmer receives an extensio.. | PU |
| 30/04 | PTA-NEWS : Biofrontera AG: Biofrontera reports results for the fiscal year 2021 | PU |
| 28/04 | PTA-NEWS : Biofrontera AG: Biofrontera shifts the publication of the Annual Report 2021 to.. | PU |
| 14/04 | PTA-NEWS : Biofrontera AG: Biofrontera announces conference call to be held on April 29, 2.. | PU |
| 04/04 | PTA-NEWS : Biofrontera AG: Governmental price decree for Ameluz® withdrawn in Spain | PU |
| 04/04 | PTA-NEWS : Biofrontera AG: Statement of Biofrontera AG on the open letter of Maruho Deutsc.. | PU |
| 14/03 | PTA-NEWS : Biofrontera AG: Biofrontera improves the brand protection of Ameluz®-PDT in the.. | PU |
| 10/03 | BIOFRONTERA : files Form 15F to suspend SEC Reporting Requirements and starts trading Leve.. | PU |
| 09/03 | PTA-NEWS : Biofrontera AG: Biofrontera files Form 15F to suspend SEC Reporting Requirement.. | PU |
| 24/02 | BIOFRONTERA AG : Management Board and supervisory board are going to submit proposals for .. | PU |
| 22/02 | BIOFRONTERA AG : Changes in the supervisory board - Form 6-K | PU |
| 15/02 | BIOFRONTERA : decides to delist ADS from Nasdaq to reduce complexity and costs - Form 6-K | PU |
| 14/02 | Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costs | AQ |
| 01/02 | BIOFRONTERA : announces progress of phase III study for the treatment of sBCC with Ameluz®.. | PU |
| 01/02 | PTA-NEWS : Biofrontera AG: Biofrontera AG announces progress of phase III study for the tr.. | PU |
| 13/01 | BIOFRONTERA : announces preliminary revenue figures for the full year 2021 - Form 6-K | PU |
| 2021 | BIOFRONTERA : announces reduction of shareholding in Biofrontera Inc. below 50% - Form 6-K | PU |
| 2021 | BIOFRONTERA AKTIENGESELLSCHAFT DECEM : 00 AM - Form 6-K | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera AG announces results of the elections for the new S.. | PU |
| 2021 | BIOFRONTERA : enrolls first patient to phase IIb clinical study evaluating Ameluz® / BF-Rh.. | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera enrolls first patient to phase IIb clinical study e.. | PU |
| 2021 | BIOFRONTERA : obtains notice of allowance for US patent on PDT-lamp and treatment method -.. | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera AG obtains notice of allowance for US patent on PDT.. | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera enrolls first patient to phase I safety study evalu.. | PU |
| 2021 | BIOFRONTERA : obtains notice of allowance for US patent on innovative illumination protoco.. | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera obtains notice of allowance for US patent on innova.. | PU |
| 2021 | BIOFRONTERA : announces timing of the departure of the CEO - Form 6-K | PU |
| 2021 | BIOFRONTERA AG : Biofrontera Inc. announces closing of USD15 million private placement - F.. | PU |
| 2021 | BIOFRONTERA : Form 6-K | PU |
| 2021 | BIOFRONTERA AG : Biofrontera Inc. announces USD 15 million private placement - Form 6-K | PU |
| 2021 | BIOFRONTERA : reaches out-of-court settlement with DUSA Pharmaceuticals, Inc - Form 6-K | PU |
| 2021 | BIOFRONTERA : announces mediation results - Form 6-K | PU |
| 2021 | Biofrontera AG announces mediation results | AQ |
| 2021 | BIOFRONTERA : Quarterly report Q3 2021 - Form 6-K | PU |
| 2021 | Biofrontera reports financial results for the third quarter and nine months ended Septe.. | GL |
| 2021 | BIOFRONTERA : announces initiation of clinical studies - Form 6-K | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera AG announces initiation of clinical studies | PU |
| 2021 | Biofrontera AG announces initiation of clinical studies | AQ |
| 2021 | CEO seeks early retirement from the Management Board - Form 6-K | PU |
| 2021 | BIOFRONTERA AG : Conference call to discuss third quarter 2021 financial results to be hel.. | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Conference call to discuss third quarter 2021 financial results.. | PU |
| 2021 | BIOFRONTERA AG : Conference call to discuss third quarter 2021 financial results to be hel.. | GL |
| 2021 | BIOFRONTERA AG : Conference call to discuss third quarter 2021 financial results to be hel.. | GL |
| 2021 | Early repayment of EIB loan - Form 6-K | PU |
| 2021 | Biofrontera is setting the path for further expansion in the world's largest pharmaceut.. | PU |
| 2021 | Biofrontera Inc. closes IPO - Form 6-K | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera is setting the path for further expansion in the U... | PU |
| 2021 | Initial public offering price of Biofrontera Inc. IPO - Form 6-K | PU |
| 2021 | Biofrontera AG approves modification of the US-IPO of Biofrontera Inc - Form 6-K | PU |
| 2021 | BIOFRONTERA : receives FDA-approval of the BF-RhodoLED® XL lamp - Form 6-K | PU |
| 2021 | BIOFRONTERA AG : receives FDA-approval of the BF-RhodoLED® XL lamp | AQ |
| 2021 | BIOFRONTERA : reports preliminary approximate revenues for the month of September 2021 (Fo.. | PU |
| 2021 | BIOFRONTERA : Leverkusen, Germany, October 1, 2021 – Biofrontera AG currently holds .. | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera reports preliminary approximate revenues for the mo.. | PU |
| 2021 | Biofrontera reports preliminary approximate revenues for the month of September 2021 | GL |
| 2021 | BIOFRONTERA : reports preliminary approximate revenues for the month of September 2021 | GL |
| 2021 | BIOFRONTERA : reports preliminary revenue for the month of August 2021 (Form 6-K) | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera reports preliminary revenue for the month of August.. | PU |
| 2021 | BIOFRONTERA : reports preliminary revenue for the month of August 2021 | AQ |
| 2021 | BIOFRONTERA : reports financial results for the six months ended June 30, 2021 (Form 6-K) | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera reports financial results for the six months ended .. | PU |
| 2021 | Biofrontera reports financial results for the six months ended June 30, 2021 | GL |
| 2021 | BIOFRONTERA AG : Conference call to discuss half-year 2021 financial results to be held on.. | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Conference call to discuss half-year 2021 financial results to .. | PU |
| 2021 | BIOFRONTERA AG : Conference call to discuss half-year 2021 financial results to be held on.. | AQ |
| 2021 | BIOFRONTERA : reports preliminary revenue for the month of July 2021 | AQ |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera enters into license and supply agreement with Medac.. | PU |
| 2021 | Biofrontera enters into license and supply agreement with Medac for the marketing of Am.. | GL |
| 2021 | BIOFRONTERA : Leverkusen, Germany, July 6, 2021 – Biofrontera AG currently holds 100.. | PU |
| 2021 | Biofrontera Inc. seeks IPO in the USA | GL |
| 2021 | BIOFRONTERA : reports preliminary revenue for the month of June 2021 (Form 6-K) | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera reports preliminary revenue for the month of June 2.. | PU |
| 2021 | Biofrontera reports preliminary revenue for the month of June 2021 | GL |
| 2021 | BIOFRONTERA : provides update on clinical developments (Form 6-K) | PU |
| 2021 | PTA-NEWS : Biofrontera AG: Biofrontera provides update on clinical developments | PU |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
